Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Green Med Solution (BGMS) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Bio Green Med Solution (BGMS) over the last 17 years, with Q3 2025 value amounting to $2.3 million.

  • Bio Green Med Solution's Change in Accured Expenses rose 30375.22% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.5 million, marking a year-over-year decrease of 25756.43%. This contributed to the annual value of -$1.8 million for FY2024, which is 71182.43% down from last year.
  • As of Q3 2025, Bio Green Med Solution's Change in Accured Expenses stood at $2.3 million, which was up 30375.22% from -$5.6 million recorded in Q2 2025.
  • Bio Green Med Solution's Change in Accured Expenses' 5-year high stood at $2.8 million during Q4 2022, with a 5-year trough of -$5.6 million in Q2 2025.
  • Moreover, its 5-year median value for Change in Accured Expenses was $254000.0 (2024), whereas its average is -$245105.3.
  • In the last 5 years, Bio Green Med Solution's Change in Accured Expenses surged by 3550000.0% in 2021 and then crashed by 226496.06% in 2025.
  • Over the past 5 years, Bio Green Med Solution's Change in Accured Expenses (Quarter) stood at $1.8 million in 2021, then skyrocketed by 53.66% to $2.8 million in 2022, then crashed by 110.78% to -$303000.0 in 2023, then skyrocketed by 185.48% to $259000.0 in 2024, then surged by 801.54% to $2.3 million in 2025.
  • Its Change in Accured Expenses was $2.3 million in Q3 2025, compared to -$5.6 million in Q2 2025 and -$5.5 million in Q1 2025.